Literature DB >> 12603444

Rural community pharmacy: a feasible site for a health promotion and screening service for cardiovascular risk factors.

Fleur Hourihan1, Ines Krass, Timothy Chen.   

Abstract

A pharmacist-delivered health promotion and screening service for cardiovascular risk factors in rural community pharmacy was implemented in the Upper Hunter Valley, New South Wales (NSW). We describe the development of the service and profile 204 participants at their initial screening. A standardised clinical protocol guided the pharmacist through delivery of the service. The mean age of participants was 44 years (SD +/- 13). Over half (54%) had a Body Mass Index (BMI) > 25, 54% had cholesterol > 5.0 mmol L-1 and 18% a systolic BP> or = 140 mmHg and/or diastolic BP >or = 90 mmHg. Most (80%) received lifestyle information (dietary, exercise or smoking cessation). One third required referral to a general practitioner. Provision of the service through community pharmacy increased the community's access to screening, 28% reported that they had never had their cholesterol measured. Since this new service was able to identify, educate and refer people at risk of cardiovascular disease in a rural community, we recommend a broader adoption through rural pharmacies.

Entities:  

Mesh:

Year:  2003        PMID: 12603444     DOI: 10.1046/j.1440-1584.2003.00468.x

Source DB:  PubMed          Journal:  Aust J Rural Health        ISSN: 1038-5282            Impact factor:   1.662


  15 in total

Review 1.  The Evidence to Support Point-of-Care Testing.

Authors:  Andrew St John
Journal:  Clin Biochem Rev       Date:  2010-08

2.  The roles of community pharmacists in cardiovascular disease prevention and management.

Authors:  J George; K McNamara; K Stewart
Journal:  Australas Med J       Date:  2011-05-31

3.  Improving health promotion to American Indians in the midwest United States: preferred sources of health information and its use for the medical encounter.

Authors:  Mugur V Geana; K Allen Greiner; Angelia Cully; Myrietta Talawyma; Christine Makosky Daley
Journal:  J Community Health       Date:  2012-12

Review 4.  Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic review.

Authors:  Marlies M E Geurts; Jaap Talsma; Jacobus R B J Brouwers; Johan J de Gier
Journal:  Br J Clin Pharmacol       Date:  2012-07       Impact factor: 4.335

5.  Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot study.

Authors:  Kevin P Mc Namara; Johnson George; Sharleen L O'Reilly; Shane L Jackson; Gregory M Peterson; Helen Howarth; Michael J Bailey; Gregory Duncan; Peta Trinder; Elizabeth Morabito; Jill Finch; Stephen Bunker; Edward Janus; Jon Emery; James A Dunbar
Journal:  BMC Health Serv Res       Date:  2010-09-07       Impact factor: 2.655

6.  Relationship between cardiovascular risk factors and high blood pressure by community pharmacists in Spain.

Authors:  Sebastián R Martínez Pérez; Pedro D Armando; Andrea C Molina Guerra; Mercé Martí Pallarés; Fernando Martínez Martínez
Journal:  Pharm World Sci       Date:  2008-12-09

7.  Attitudes toward pharmacy-based HCV/HIV testing among people who use drugs in rural Kentucky.

Authors:  Michelle Duong; Chris Delcher; Patricia R Freeman; April M Young; Hannah L F Cooper
Journal:  J Rural Health       Date:  2021-03-05       Impact factor: 4.333

8.  Making a success of providing NHS Health Checks in community pharmacies across the Tees Valley: a qualitative study.

Authors:  Rebekah J McNaughton; Nigel T A Oswald; Janet S Shucksmith; Peter J Heywood; Pat S Watson
Journal:  BMC Health Serv Res       Date:  2011-09-19       Impact factor: 2.655

9.  Migration as a form of workforce attrition: a nine-country study of pharmacists.

Authors:  Tana Wuliji; Sarah Carter; Ian Bates
Journal:  Hum Resour Health       Date:  2009-04-09

10.  The effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy setting.

Authors:  Andrew Willis; Peter Rivers; Laura J Gray; Melanie Davies; Kamlesh Khunti
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.